Research advances in plant-made flavivirus antigens.

Authors: Martínez CA,Giulietti AM,Talou JR,
Address: Cátedra de Microbiología Industrial y Biotecnología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires. Junín 956, CP 1113, C.A.B.A, Argentina.
Journal: Biotechnol Adv.

Publication: 2012 Nov;30(6):1493-505. doi: 10.1016/j.biotechadv.2012.03.004. Epub 2012 Mar 28.

abstract

Outbreaks of flaviviruses such as dengue (DV), yellow fever (YFV), Japanese encephalitis (JEV), tick-borne encephalitis (TBEV) and West Nile (WNV) affect numerous countries around the world. The fast spread of these viruses is the result of increases in the human population, rapid urbanisation and globalisation. While vector control is an important preventive measure against vector-borne diseases, it has failed to prevent the spread of these diseases, particularly in developing countries where the implementation of control measures is intermittent. As antiviral drugs against flaviviruses are not yet available, vaccination remains the most important tool for prevention. Although human vaccines for YFV, TBEV and JEV are available, on-going vaccination efforts are insufficient to prevent infection. No vaccines against DENV and WNV are available. Research advances have provided important tools for flavivirus vaccine development, such as the use of plants as a recombinant antigen production platform. This review summarises the research efforts in this area and highlights why a plant system is considered a necessary alternative production platform for high-tech subunit vaccines.

Related Articles
Review Advances in flavivirus vaccine development.
IDrugs. 2010
Review Advances in flavivirus vaccine development.
Coller BA, Clements DE, Martyak T, Yelmene M, Thorne M, Parks DE. IDrugs. 2010 Dec; 13(12):880-4.
Review Traditional and novel approaches to flavivirus vaccines.
Int J Parasitol. 2003
Review Traditional and novel approaches to flavivirus vaccines.
Pugachev KV, Guirakhoo F, Trent DW, Monath TP. Int J Parasitol. 2003 May; 33(5-6):567-82.
Review New developments in flavivirus vaccines with special attention to yellow fever.
Curr Opin Infect Dis. 2005
Review New developments in flavivirus vaccines with special attention to yellow fever.
Pugachev KV, Guirakhoo F, Monath TP. Curr Opin Infect Dis. 2005 Oct; 18(5):387-94.
Review Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
Biologicals. 2010
Review Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
Chávez JH, Silva JR, Amarilla AA, Moraes Figueiredo LT. Biologicals. 2010 Nov; 38(6):613-8.
Review Flaviviruses and flavivirus vaccines.
Vaccine. 2012
Review Flaviviruses and flavivirus vaccines.
Heinz FX, Stiasny K. Vaccine. 2012 Jun 19; 30(29):4301-6.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.